Abstract:Background Pencil beam scanning (PBS) proton therapy for moving targets is known to be impacted by interplay effects between the scanning beam and organ motion. While respiratory motion in the thoracic region is the major cause for organ motion, interplay effects depend on the delivery characteristics of proton accelerators. Purpose To evaluate the impact of different types of PBS proton accelerators and spot sizes on interplay effects, mitigations, and plan quality for Stereotactic Body Radiation Therapy (SBRT) treatment of non‐small cell lung cancer (NSCLC). Methods Twenty NSCLC patients treated with photon SBRT were selected to represent varying tumor volumes and respiratory motion amplitudes (median: 0.6 cm with abdominal compression) for this retrospective study. For each patient, plans were created using: (1) cyclotron‐generated proton beams (CPB) with spot sizes of σ = 2.7–7.0 mm; (2) linear accelerator proton beams (LPB) (σ = 2.9–5.5 mm); and (3) linear accelerator proton minibeams (LPMB) (σ = 0.9–3.9 mm). The energy switching time is one second for CPB, and 0.005 s for LPMB and LPB. Plans were robustly optimized on the gross tumor volume (GTV) using each individual phase of four‐dimensional computed tomography (4DCT) scans. Initially, single‐field optimization (SFO) plans were evaluated; if the plan quality did not meet the dosimetric requirement, multi‐field optimization (MFO) was used. MFO plans were created for all patients for comparisons. For each patient, all plans were normalized to have the same dose received by 99% of the GTV. Interplay effects were evaluated by computing the dose on 10 breathing phases, based on the spot distribution. Volumetric repainting (VR) was performed 2–6 times for each plan. We compared volume receiving 100% of the prescribed dose (V100%RX) of the GTV, and normal lung V20Gy. Results Twelve of 20 plans can be optimized sufficiently with SFO. SFO plans were less sensitive to the interplay effect compared to MFO plans in terms of target coverage for both LPB and LPMB. The following comparisons showed results utilizing the MFO technique. In the interplay evaluation without repainting, the mean V100%RX of the GTV were 99.42 ± 0.6%, 97.52 ± 3.9%, and 94.49 ± 7.3% for CPB, LPB, and LPMB plans, respectively. Following VR (2 × for CPB; 3 × for LPB; 5 × for LPMB), V100%RX of the GTV were improved (on average) by 0.13%, 1.84%, and 4.63%, respectively, achieving the acceptance criteria of V100%RX > 95%. Because of fast energy switch in linear accelerator proton machines, the delivery time for VR plans was the lowest for LPB plans, while delivery time for LPMB was on average 1 min longer than CPB plans. The advantage of small spot machines was better sparing in normal lung V20Gy, even when VR was applied. Conclusion In the absence of repainting, proton machines with large spot sizes generated more robust plans against interplay effects. The number of VR increased with decreasing spot sizes to achieve the acceptance criteria. VR improved the plan robustness against interplay effects for modalities with small spot sizes and fast energy changes, preserving the low dose sparing aspect of the LPMB, even when motion is included.

Explore the feasibility of using spot-scanning proton arc therapy for a synchrotron accelerator-based proton therapy system - A simulation study

Lung Stereotactic Body Radiotherapy (SBRT) Using Spot-Scanning Proton Arc (SPArc) Therapy: A Feasibility Study

Development of a standalone delivery sequence model for proton arc therapy

Impact Of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy And Vmat Delivery For Prostate Cancer

A novel planning framework for efficient spot-scanning proton arc therapy via particle swarm optimization (SPArc-particle swarm)

Explore the Potential Clinical and Dosimetric Improvements for Brain Cancer Proton Beam Treatment Based on the New Delivery and Planning Technique Developments - Collimator Based Intensity Modulated Proton Therapy and Spot-Scanning Proton Arc Therapy

The first investigation of the dosimetric perturbations from the spot position errors in spot-scanning arc therapy (SPArc)

A Novel Ultrahigh-Dose-Rate Proton Therapy Technology: Spot-Scanning Proton Arc Therapy + FLASH (SPLASH)

Novel Hybrid Scattering- and Scanning-Beam Proton Therapy Approach

Technical note: Optimizing spot‐scanning proton arc therapy with a novel spot sparsity approach

Treatment planning in arc proton therapy: Comparison of several optimization problem statements and their corresponding solvers

A Novel Ultra-High Dose Rate Proton Therapy Technology: Spot-Scanning Proton Arc Therapy FLASH (SPLASH)

Mixed-size spot scanning with a compact large momentum acceptance superconducting (LMA-SC) gantry beamline for proton therapy

A Novel Hybrid Planning Approach to Allow More Patients Benefited by the Intensity Modulated Proton Therapy

PO-0916: Explore the Future of of Proton Hypo-Fractionation Treatment - Spot-scanning Proton Arc Therapy

Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams

Developing an accurate model of spot-scanning treatment delivery time and sequence for a compact superconducting synchrocyclotron proton therapy system

Cyclotron and linear accelerator generated scanning proton beams for lung cancer SBRT: Interplay effects and mitigations

Proton energy optimization and reduction for intensity-modulated proton therapy.

Emulating the Delivery of Sawtooth Proton Arc Therapy Plans on a Cyclotron-Based Proton Beam Therapy System

Feasibility Study of Hybrid Inverse Planning with Transmission Beams and Single-energy Spread-out Bragg Peaks for Proton Flash Radiotherapy